Where is Omeros headquartered?

Omeros is located in Seattle, WA.

Who invested in Omeros?

Omeros has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Omeros?

Omeros closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

omeros.com

Omeros

Omeros discovers, develops and commercializes small-molecule and protein therapeutics for inflammation and disorders of central nervous system.

Business Model:

Revenue: $97.7M

Employees: 201-500

Geographic Data

Address: 201 Elliott Avenue West

City: Seattle

State: WA

Zip: 98119

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$100M

Raised Total:

$88M

Social

Facebook

Twitter

Crunchbase

Metrics

2,400,134Website Global Rank

7,595Website Monthly Traffic

Twitter Followers

Description

Omeros discovers, develops and commercializes small-molecule and protein therapeutics for inflammation and disorders of central nervous system.

Contact Phone:
+12066765000

Contact Email:

IPO Details

Omeros went public on 10/8/2009 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/8/2009

IPO Valuation:
$84M

Ticker Symbol:
OMER

IPO Price:
$20.03/share

Amount Raised:
$84M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2007	Private Equity Round		$0	Stanley Medical Research Institute Stanley Medical Research Institute
7/2012	Post-IPO Equity		$34.5M
1/2009	Grant	1	$465k	Michael J. Fox Foundation Michael J. Fox Foundation
2/2012	Grant	1	$1M	National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA)
11/2010	Grant		$1.7M
9/2012	Grant	1	$700k	National Institute of Mental Health National Institute of Mental Health
1/2009	Grant		$0	Stanley Medical Research Institute Stanley Medical Research Institute
10/2010	Post-IPO Equity	1	$20M	Vulcan Capital Vulcan Capital
2/2007	Series E		$0	Aravis Ventures ARCH Venture Partners Novartis Venture Fund Southern Cross Venture Partners Stanley Medical Research Institute The Grosvenor Funds Trevi Health Ventures Washington Research Foundation WRF Capital Aravis Ventures ARCH Venture Partners Novartis Venture Fund Southern Cross Venture Partners Stanley Medical Research Institute The Grosvenor Funds Trevi Health Ventures Washington Research Foundation WRF Capital
1/2015	Post-IPO Equity		$84M
3/2014	Post-IPO Debt	2	$32M	Oxford Finance LLC MidCap Financial Oxford Finance LLC MidCap Financial
3/2014	Post-IPO Equity		$37.8M
10/2010	Grant		$0	Life Sciences Discovery Fund Life Sciences Discovery Fund
5/2016	Post-IPO Debt	2	$20M	Oxford Finance LLC East West Bank Oxford Finance LLC East West Bank
7/2010	Post-IPO Equity	1	$40M	Azimuth Opportunity Azimuth Opportunity
11/2018	Post-IPO Debt		$210M
1/2016	Post-IPO Debt	2	$70M	Oxford Finance LLC East West Bank Oxford Finance LLC East West Bank
8/2017	Post-IPO Equity		$68M
11/2016	Post-IPO Debt	1	$125M	CRG CRG CRG CRG
10/2016	Debt		-
10/2009	IPO		$68.2M
8/2020	Post-IPO Equity		$100M
12/2019	Post-IPO Equity		-
8/2016	Post-IPO Equity		$40M
10/2016	Debt		-
12/2019	Post-IPO Equity		-

Acquisitions

Announced Date	Name	Price
9/2006	Nura

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details